A detailed history of Resonant Capital Advisors, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 29,630 shares of MDT stock, worth $2.35 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
29,630
Previous 28,852 2.7%
Holding current value
$2.35 Million
Previous $2.38 Million 8.67%
% of portfolio
0.22%
Previous 0.23%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$82.84 - $88.09 $64,449 - $68,534
778 Added 2.7%
29,630 $2.58 Million
Q4 2023

Jan 31, 2024

SELL
$69.43 - $83.43 $8,123 - $9,761
-117 Reduced 0.4%
28,852 $2.38 Million
Q3 2023

Oct 31, 2023

SELL
$78.22 - $90.4 $15,644 - $18,080
-200 Reduced 0.69%
28,969 $2.27 Million
Q2 2023

Jul 25, 2023

BUY
$79.47 - $91.38 $423,018 - $486,415
5,323 Added 22.32%
29,169 $2.57 Million
Q1 2023

Apr 21, 2023

BUY
$76.72 - $87.58 $1.21 Million - $1.38 Million
15,731 Added 193.85%
23,846 $1.92 Million
Q4 2022

Jan 23, 2023

BUY
$76.18 - $87.74 $218,255 - $251,375
2,865 Added 54.57%
8,115 $0
Q3 2022

Oct 20, 2022

BUY
$80.75 - $95.31 $60,966 - $71,959
755 Added 16.8%
5,250 $428,000
Q2 2022

Jul 12, 2022

BUY
$87.4 - $113.09 $55,324 - $71,585
633 Added 16.39%
4,495 $406,000
Q1 2022

Apr 19, 2022

BUY
$100.58 - $112.38 $388,439 - $434,011
3,862 New
3,862 $437,000
Q4 2021

Jan 26, 2022

SELL
$99.53 - $127.75 $174,277 - $223,690
-1,751 Closed
0 $0
Q3 2021

Oct 18, 2021

BUY
$122.75 - $135.17 $214,935 - $236,682
1,751 New
1,751 $221,000
Q1 2020

May 14, 2020

SELL
$72.92 - $121.3 $219,051 - $364,385
-3,004 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$104.49 - $114.54 $313,887 - $344,078
3,004 New
3,004 $341,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $106B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Resonant Capital Advisors, LLC Portfolio

Follow Resonant Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.